Today we announced the landmark overall survival results from our Phase 3 CARES-310 trial in first-line #uHCC. The results will be presented at an in-person poster presentation on June 1 at #ASCO2024. Read more here: https://lnkd.in/gsSMAVpn #ElevarAtASCO
Elevar Therapeutics
Pharmaceutical Manufacturing
Fort Lee, New Jersey 16,508 followers
Elevating Outcomes * Evolving Therapeutic Potential * Engaging With Purpose
About us
Elevar Therapeutics is a rapidly growing, fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. Our experience is rooted in oncology, and we apply the same rigor and diligence that comes with this knowledge to identifying and developing promising medicines for complex yet under-treated health conditions across a range of therapeutic areas. Elevating Outcomes: We take a relentless and inventive approach towards developing and advancing next-generation, best-in-class therapies that have the potential to set new standards of care and improve treatment experiences. Evolving Therapeutic Potential: We identify areas where we can develop, build upon or evolve medicines that offer patients improved clinical outcomes. Engaging With Purpose: We are committed to engaging with the highest ethical standards, driven by a passion to address the underserved needs of patients, caregivers, and healthcare providers.
- Website
-
https://elevartherapeutics.com
External link for Elevar Therapeutics
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Fort Lee, New Jersey
- Type
- Privately Held
- Founded
- 2019
Locations
-
Primary
Get directions
1 Bridge Plaza N
850
Fort Lee, New Jersey 07024, US
Employees at Elevar Therapeutics
Updates
-
DYK? Pride Month is celebrated each year to honor the 1969 Stonewall Uprising in Manhattan which occurred in June. This was a critical point in history for the Gay Rights Movement. https://lnkd.in/d3RXF9s #ElevarCares #PrideMonth
-
-
Elevar is headed to #BIO2024 to discuss collaborations for our leading oncology asset rivoceranib. Connect with us through the BIO One-on-One Partnering system to meet with our CCO Paul Friel or CFO Wade Smith. If you missed our CARES-310 landmark overall survival analysis for #uHCC at #ASCO2024, learn more here: https://lnkd.in/emrma9iu
-
-
The Elevar Therapeutics team is LIVE at #ASCO2024. Stop by booth 12119 for a sweet snack and to learn about our CARES-310 landmark overall survival analysis for first line #uHCC. #ElevaratASCO #ElevatingOutcomes
-
-
**ASCO Poster 90** Landmark Overall Survival results from our Phase 3 CARES-310 trial in first-line #uHCC will be presented at an in-person poster presentation tomorrow at #ASCO2024. https://lnkd.in/eRJ_ETSQ #ElevarAtASCO
-
-
Hear about Elevar's clinical advances in #uHCC at #ASCO24. The CARES-310 study landmark overall survival analysis will be presented at an in-person poster presentation on June 1 from 1:30 PM - 4:30 PM CDT - abstract number 4110. Learn more here: https://lnkd.in/e6AeR7UB #ElevarAtASCO #ElevatingOutcomes
-
Meet Gerald Walis, our Senior Director, Quality Assurance Compliance. Jerry is a hard worker who is focused and determined. He is always willing to take on new challenges and prioritizes the safety of the patient above all else. We are grateful to have Jerry on our team! https://lnkd.in/ez8bsshX #FacesofElevar #ElevarCulture
-
-
#ASCO24 is almost here. Our team is looking forward to presenting our latest #uHCC data and meeting industry professionals from around the world. Stop by and meet the team! See you soon. https://lnkd.in/eKFrSbpV #ElevarAtASCO
-
-
This Women's Health Week, lets celebrate the strength, resilience, and beauty of women everywhere. Take a moment to prioritize your health and well-being—it's a gift you can give yourself. To improve your physical and mental health, you can: · Get regular checkups · Get active · Eat a healthy and balanced diet #ElevarCares #WomensHealthWeek
-